We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Their warning depends on whether negotiations for a post-Brexit Britain do not offer freedom of movement for people, capital and goods.
The ex girlfriend of Ben Butler, who was jailed for murdering his daughter Ellie, has spoken of the abuse she suffered with him.
Queen Charlotte's and Chelsea Hospital takes Finnish inspiration to give parents baby boxes, credited with reducing infant mortality rates.